LONDON, July 29, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Friday, July 26, 2013, shares of biotech companies ended mostly lower even as the broader market posted gains. The major movers in the industry included Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Geron Corporation (NASDAQ: GERN), Incyte Corporation (NASDAQ: INCY), and Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI). AAAResearchReports.com has released full comprehensive research on ARNA, GERN, INCY, and SPPI. These free technical analyses can be downloaded by signing up at:
Shares of Arena Pharmaceuticals, Inc. fell sharply on Friday, finishing at $6.86, down 2.14% from its previous trading session's closing price. The company's shares oscillated between $6.83 and $7.01. A total of 3.01 million shares were traded, which is below the daily average volume of 5.84 million. Arena's shares have fallen by 10.91% in the last one month as compared to a loss of 0.03% in the S&P 500. A free technical analysis on ARNA available by signing up at:
Geron Corporation's stock fell sharply on Friday, extending its losses for the week. The company's shares oscillated between $1.38 and $1.44 before ending the day 4.17% lower at $1.38. A total of 260,089 shares were traded, which is below the daily average volume of 994,053. The company's shares fell by 6.76% last week. Nonetheless, the stock has advanced 21.05% in the last three
|SOURCE AAA Research Reports|
Copyright©2012 PR Newswire.
All rights reserved